BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 35156630)

  • 1. Updates in ANCA-associated vasculitis.
    Ross C; Makhzoum JP; Pagnoux C
    Eur J Rheumatol; 2022 Jul; 9(3):153-166. PubMed ID: 35156630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in ANCA-associated vasculitis.
    Pagnoux C
    Eur J Rheumatol; 2016 Sep; 3(3):122-133. PubMed ID: 27733943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Therapies for ANCA-associated Vasculitis.
    Monti S; Brandolino F; Milanesi A; Xoxi B; Delvino P; Montecucco C
    Curr Rheumatol Rep; 2021 Apr; 23(6):38. PubMed ID: 33909172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ANCA-associated vasculitis].
    Krasselt ML; Holle JU
    Inn Med (Heidelb); 2022 Sep; 63(9):947-960. PubMed ID: 35925127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California.
    Singh D; Sukumaran S
    Pediatr Rheumatol Online J; 2023 Jul; 21(1):66. PubMed ID: 37400890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANCA associated vasculitis (AAV): a review for internists.
    Yaseen K; Mandell BF
    Postgrad Med; 2023 Jan; 135(sup1):3-13. PubMed ID: 35831990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis.
    Berti A; Cornec D; Dua AB
    Rheum Dis Clin North Am; 2023 Aug; 49(3):545-561. PubMed ID: 37331732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management.
    Plumb LA; Oni L; Marks SD; Tullus K
    Pediatr Nephrol; 2018 Jan; 33(1):25-39. PubMed ID: 28062909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of anti-neutrophil cytoplasmic antibody-associated vasculitis: what has changed in the last 10 years?
    Suresh E
    Br J Hosp Med (Lond); 2022 Feb; 83(2):1-10. PubMed ID: 35243884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice.
    Chevet B; Cornec D; Casal Moura M; Cornec-Le Gall E; Fervenza FC; Warrington KJ; Specks U; Berti A
    Rheumatology (Oxford); 2023 May; 62(5):1787-1803. PubMed ID: 36315063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan.
    Alvarez L; Kambham N; Su R
    J Nephrol; 2023 Nov; 36(8):2365-2370. PubMed ID: 37036661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ANCA-Associated Vasculitides].
    Stegert M; Neumann T; Daikeler T
    Ther Umsch; 2022 Jun; 79(5):229-237. PubMed ID: 35583025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of primary vasculitides with biologic and novel small molecule medications.
    Serling-Boyd N; Wallace ZS
    Curr Opin Rheumatol; 2021 Jan; 33(1):8-14. PubMed ID: 33164993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.